
Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
Publication
, Journal Article
Tamayo, SG; Simeone, JC; Nordstrom, BL; Patel, MR; Yuan, Z; Sicignano, NM; Peacock, WF
Published in: J Am Coll Cardiol
September 6, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
September 6, 2016
Volume
68
Issue
10
Start / End Page
1144 / 1146
Location
United States
Related Subject Headings
- Stroke
- Rivaroxaban
- Risk Factors
- Risk Assessment
- Humans
- Hemorrhage
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tamayo, S. G., Simeone, J. C., Nordstrom, B. L., Patel, M. R., Yuan, Z., Sicignano, N. M., & Peacock, W. F. (2016). Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation. J Am Coll Cardiol, 68(10), 1144–1146. https://doi.org/10.1016/j.jacc.2016.06.028
Tamayo, Sally G., Jason C. Simeone, Beth L. Nordstrom, Manesh R. Patel, Zhong Yuan, Nicholas M. Sicignano, and W Frank Peacock. “Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.” J Am Coll Cardiol 68, no. 10 (September 6, 2016): 1144–46. https://doi.org/10.1016/j.jacc.2016.06.028.
Tamayo SG, Simeone JC, Nordstrom BL, Patel MR, Yuan Z, Sicignano NM, et al. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation. J Am Coll Cardiol. 2016 Sep 6;68(10):1144–6.
Tamayo, Sally G., et al. “Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.” J Am Coll Cardiol, vol. 68, no. 10, Sept. 2016, pp. 1144–46. Pubmed, doi:10.1016/j.jacc.2016.06.028.
Tamayo SG, Simeone JC, Nordstrom BL, Patel MR, Yuan Z, Sicignano NM, Peacock WF. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation. J Am Coll Cardiol. 2016 Sep 6;68(10):1144–1146.

Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
September 6, 2016
Volume
68
Issue
10
Start / End Page
1144 / 1146
Location
United States
Related Subject Headings
- Stroke
- Rivaroxaban
- Risk Factors
- Risk Assessment
- Humans
- Hemorrhage
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- 3201 Cardiovascular medicine and haematology